perifosine has been researched along with erucylphosphocholine in 6 studies
| Studies (perifosine) | Trials (perifosine) | Recent Studies (post-2010) (perifosine) | Studies (erucylphosphocholine) | Trials (erucylphosphocholine) | Recent Studies (post-2010) (erucylphosphocholine) |
|---|---|---|---|---|---|
| 245 | 31 | 140 | 42 | 0 | 9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, MM; Hong, J; Joh, EH; Kim, B; Kim, DH; Kim, Y; Lee, YS; Oh, YI | 1 |
| Berger, MR; Eibl, H; Konstantinov, SM | 1 |
| Carrasco, MP; Jiménez-López, JM; Marco, C; Ríos-Marco, P; Segovia, JL | 1 |
| van Blitterswijk, WJ; Verheij, M | 1 |
| Dakir, EL; Dakir, el H; López-Abán, J; Mollinedo, F; Muro, A; Varela-M, RE; Yepes, E | 1 |
| Cabello, J; Mohler, WA; Mollinedo, F; Reis-Sobreiro, M; Rodríguez-Matellán, AG; Sáenz-Narciso, B; Sánchez-Blanco, A | 1 |
1 review(s) available for perifosine and erucylphosphocholine
| Article | Year |
|---|---|
Anticancer mechanisms and clinical application of alkylphospholipids.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Membrane; Endocytosis; Humans; Neoplasms; Organophosphates; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phospholipid Ethers; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Quaternary Ammonium Compounds; Signal Transduction | 2013 |
5 other study(ies) available for perifosine and erucylphosphocholine
| Article | Year |
|---|---|
Synthesis and biological evaluation of cyclopentane-linked alkyl phosphocholines as potential anticancer agents that act by inhibiting Akt phosphorylation.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cyclopentanes; Humans; Inhibitory Concentration 50; Phosphorylation; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Stereoisomerism | 2012 |
BCR-ABL influences the antileukaemic efficacy of alkylphosphocholines.
Topics: Apoptosis; Cell Adhesion; Cell Survival; Dose-Response Relationship, Drug; Fusion Proteins, bcr-abl; HL-60 Cells; Humans; Molecular Structure; Phosphorylcholine; Structure-Activity Relationship; Tumor Cells, Cultured | 1999 |
Disruption of cellular cholesterol transport and homeostasis as a novel mechanism of action of membrane-targeted alkylphospholipid analogues.
Topics: Antineoplastic Agents; Biological Transport; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane; Cholesterol; Drug Delivery Systems; Endoplasmic Reticulum; Gene Expression Regulation, Neoplastic; Homeostasis; Humans; Liver Neoplasms; Membrane Microdomains; Phospholipid Ethers; Phosphorylcholine; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
In vitro and in vivo anti-schistosomal activity of the alkylphospholipid analog edelfosine.
Topics: Animals; Antineoplastic Agents; Antiparasitic Agents; Apoptosis; Female; Mice; Phospholipid Ethers; Phosphorylcholine; Schistosoma mansoni; Schistosomiasis mansoni | 2014 |
Caenorhabditis elegans as a platform to study the mechanism of action of synthetic antitumor lipids.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caenorhabditis elegans; Cell Line, Tumor; Cholesterol; Drug Resistance; Embryo, Nonmammalian; Embryonic Development; Humans; Insulin-Like Growth Factor I; Larva; Membrane Microdomains; Phospholipid Ethers; Phosphorylcholine | 2014 |